Using MRI to assess hippocampal grading, physicians may be able to predict Alzheimer’s disease up to seven years before dementia.
MRI of the brain may detect Alzheimer’s disease up to seven years before signs appear, according to a study published in Human Brain Mapping.
Researchers from France, Canada, Denmark, and Spain undertook a prospective study to assess the efficiency of an MR-based hippocampal grading score that might detect incident dementia in patients who were cognitively intact. The subjects were followed for 12 years.
The study began with 538 subjects at baseline with Mini-Mental State Evaluation (MMSE) higher than 24 and analyzable MRI. At the end of the study, there were 309 subjects who did not have dementia.
The results showed that hippocampal grading for dementia predicted accuracy up to 72.5%, seven years before subjects began to show signs of Alzheimer’s disease while hippocampal volume was accurate up to 56.9%, and the Mini-Mental State Evaluation (MMSE) 56.9%. There was a gain of percentage points for hippocampal grade (73%) over hippocampal volume (64.6%).[[{"type":"media","view_mode":"media_crop","fid":"42998","attributes":{"alt":"MRI","class":"media-image media-image-right","id":"media_crop_4268438543649","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4680","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 120px; width: 160px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©nav/Shutterstock.com","typeof":"foaf:Image"}}]]
“Compared with previous studies investigating new biomarkers for AD prediction over much shorter periods, the very long followup of the Three-City cohort demonstrates the important clinical potential of the proposed imaging biomarker,” the authors wrote. “The high accuracy obtained with this new imaging biomarker paves the way for computer-based prognostic aides to help the clinician identify cognitively intact subjects that are at high risk to develop AD,” they concluded.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.